Osimertinib Mesylate and Prialt

• Generic Name: osimertinib
• Dosage Forms: n.a.
• Other Brand Names: Tagrisso

First-line treatment of metastatic NSCLC in patients with epidermal growth factor receptor (EGFR) exon 19 deletions (del19) or exon 21 (L858R) substitution mutations (as detected by an FDA-approved diagnostic test).

Treatment of metastatic NSCLC in patients with EGFR T790M mutation (as detected by an FDA-approved diagnostic test) who have experienced disease progression during or after EGFR tyrosine kinase inhibitor therapy.

Designated an orphan drug by FDA for treatment of EGFR mutation-positive NSCLC.

• Generic Name: ziconotide
• Dosage Forms: injection, solution
• Other Brand Names: Prialt

Prialt is a non-narcotic pain reliever that works by blocking pain signals from the nerves to the brain.

Prialt is used to treat severe chronic pain in people who cannot use or do not respond to standard pain-relieving medications.

Prialt may also be used for other purposes not listed in this medication guide.